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In this issue of Cell Stem Cell, Esteban et al. (2009) report that vitamin C enhances the reprogramming effi-
ciency of mouse and human fibroblasts transduced with three (Oct4/Klf4/Sox2) or four (Oct4/Klf4/Sox2/
cMyc) factors. Vitamin C can alleviate cell senescence by p53 repression andmay accelerate reprogramming
by synergizing with epigenetic regulators.In this issue, Pei and colleagues reveal
that a natural compound, vitamin C, can
not only improve the efficiency of existing
reprogramming protocols for both mouse
and human somatic cells, including fibro-
blasts and nonfibroblasts, but may also
promote the transition of partially reprog-
rammed induced pluripotent stem cells
(iPSCs) to a fully reprogrammed state
(Esteban et al., 2009). Notably, in the
three years since the first generation of
iPSCs by Yamanaka’s group in 2006
(Takahashi and Yamanaka, 2006), several
small molecules and growth factors
have been identified that greatly improve
reprogramming efficiency (reviewed in
Feng et al., 2009) (Figure 1). Some of
these molecules are epigenetic regulating
factors such as valproic acid (VPA), a
histone deacetylase inhibitor; BIX01294,
an inhibitor of the G9a histone methyl-
transferase; RG108 and AZA, DNA
methyltransferase (DNMT) inhibitors; and
Tranylcypromine, an inhibitor of lysine-
specific demethylase 1 (Li et al., 2009).
Other factors that have been shown to
influence the reprogramming process
function through cell-signaling pathways,
including the Wnt signaling agonists
Wnt3a or CHIR99021, the TGF-beta
receptor antagonists SB431542 and
E616452 (Woltjen and Stanford, 2009),
the MEK-ERK pathway antagonist
PD0325901 (Li et al., 2009), and the
L-typecalciumchannel agonistBayK8644.
In addition, kenpaullone, an inhibitor of
CDK and GSK3, has been reported to be
able to substitute for KLF4 in iPSC gener-
ation, although its mechanism of action is
not yet clear and might not be mediated
by CDK or GSK3 (Lyssiotis et al., 2009).
In contrast to the small molecules listed
above, vitamin C is a natural compoundand an essential nutrient that is vital to
human health.
The discovery of vitamin C as a reprog-
rammingenhancer arose fromametabolic
study of the reprogramming process.
Pei’s group first found that one of the
important metabolic activities that occur
during the early reprogramming process
is a significant increase in the level of
reactive oxygen species (ROS) in Oct4/
Sox2/Klf4-transduced mouse embryonic
fibroblasts (MEFs) (Esteban et al., 2009),
which might induce senescence and
cause the transduced cells to be more
resistant to reprogramming. However,
the inclusion of c-Myc in the cocktail
led to a marked decrease in ROS levels
and also correlated with an improvement
in reprogramming efficiency. Moreover,
several genes regulating the antioxidant
cell response, such as superoxide dismu-
tase 1 and 2, were also upregulated
in the Oct4/Klf4/Sox2/cMyc-transduced
MEF cells. These observations suggest
that the antioxidant defense system
might be an important metabolic regula-
tion pathway for the early steps of the
reprogramming process. However, after
testing several antioxidants such as nace-
tylcysteine and resveratrol, the authors
found that only vitamin C could improve
iPSC generation, even in the presence of
c-Myc, which suggests that the positive
effect of vitamin C on reprogramming effi-
ciency is probably independent of its
function as an antioxidant. These results
indicated that other biological mecha-
nisms of vitamin C might be involved in
upregulating reprogramming efficiency.
Several recent studies have demon-
strated that p53, a tumor-suppressor
gene, plays critical roles in somatic cell
reprogramming.Thesilencingofp53couldCell Stem Cesignificantly increase the reprogramming
efficiency of both mouse and human
somatic cells (discussed in Deng, 2009).
Moreover, cell senescence, which is char-
acterized by p53, p16INK4a, and p21CIP1
upregulation, impairs the successful
reprogramming of somatic cells to pluripo-
tent stem cells. Various results from the
Esteban et al. study, such as an increase
in cell proliferation and cell lifespan exten-
sion, suggest that vitaminC is able to over-
come the senescence roadblock during
the reprogramming process. Pei’s group
further showed that the alleviation of cell
senescence by vitamin C may depend on
reducing but not abolishing p53 and p21
expression levels in the fibroblasts trans-
duced with Oct4/Klf4/Sox2 (Esteban
et al., 2009). It has also been reported
that vitamin C can inhibit p53-induced
senescence in human bladder cancer EJ
cells, probably because of suppression of
ROS production and p38 MAPK activity
(Kim et al., 2008). Altogether, these find-
ings suggest that the improvement in
reprogramming efficiency mediated by
vitamin C may result from alleviating cell
senescence via p53 repression. Impor-
tantly, vitamin C doesn’t seem to eliminate
p53 expression entirely and thus the
resulting iPSCs may harbor less onco-
genic potential relative to p53 null pluripo-
tent cell lines. Therefore, vitamin C may
be a valuable addition to reprogramming
cocktails as a safe, natural compound
used for suppressing the p53 pathway
and facilitating iPSC generation. This pos-
sibility needs to be confirmed by exam-
ining chromosome stability and tumorige-
nicity of the resulting cells.
In addition, Esteban et al. (2009)
showed that vitamin C could accelerate
transcriptome changes that occur duringll 6, January 8, 2010 ª2010 Elsevier Inc. 1
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Figure 1. Reported Small Molecules and Growth Factors that Improve Reprogramming
Efficiency
The small molecules and growth factors that target particular signaling pathways are indicated in blue.
Small molecules that regulated epigenetic events are drawn in orange.
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Previewsthe reprogramming process and also
promote the conversion of partially repro-
grammed iPSCs to fully reprogrammed
iPSCs. Although an ERK inhibitor and a
GSK3 inhibitor (also known as ‘‘2i’) were
reported to have similar effects (reviewed
in Feng et al., 2009), vitamin C did not
inhibit ERK activation in the reprogram-
ming setting and thus probably functions
through an alternate pathway. The Yama-
naka lab recently reported that hypoxic
conditions can also improve reprogram-
mingefficiency for bothmouseandhuman
cells (Yoshida et al., 2009). In their current
work, Pei’s group reveal that several
hypoxia inducible factor (HIF) target genes
are upregulated during the iPSC genera-
tion process and that expression of these
genes is further increased with vitamin C
treatment. It has been reported that the
stabilization of HIFa and the activation of
HIF transcriptional activity, which are the
critical characteristics of the hypoxic2 Cell Stem Cell 6, January 8, 2010 ª2010 Elstate, are promoted by the inhibition of
HIF-hydroxylase activity when cells are
treated with ascorbate (Schofield and
Ratcliffe, 2004). Collectively, these results
suggest that vitamin C might improve
reprogramming efficiency in part by func-
tioning as an agonist for genes that are
typically downstream of hypoxia. In addi-
tion, there is evidence to show that
vitamin C could be a cofactor for histone
demethylases such as JMJD1A, which
demethylate specific amino acids in his-
tone proteins such as histone 3 lysine 9
(H3K9). It has been reported that an
inhibitor of G9a (the major mammalian
H3K9 methyltransferase), BIX01294, is
able to improve reprogramming efficiency
(reviewed in Feng et al., 2009). Therefore,
vitamin C might also promote histone
demethylation in order to improve the
reprogramming efficiency of Oct4/KLF4/
Sox2/cMyc or Oct4/KLF4/Sox2-trans-
duced fibroblasts.sevier Inc.In summary, Esteban et al. (2009)
identified that vitamin C, a natural nutri-
tional compound crucial for human health,
plays an important role in promoting
somatic cell reprogramming to pluripo-
tency. Although the specific mecha-
nism(s) responsible for the effect of
vitamin C on reprogramming remains
unclear, alleviation of cell senescence by
vitamin C may synergize with its other
biological functions, such as its function
as an agonist for the HIF pathway and
a cofactor for histone demethylases, and
account for the improvement in the
reprogramming efficiency (Figure 1). Alto-
gether, this discovery of the effect of
vitamin C on reprogramming not only
sheds new light on the future study of
reprogramming mechanism but also facil-
itates our ability to explore more efficient
and safer methods to obtain fully reprog-
rammed iPSCs from somatic cells.REFERENCES
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